Streetbeat News

Stock Prices

ORLY

Stephens & Co. analyst Daniel Imbro has reiterated an Overweight rating on O'Reilly Automotive (NASDAQ:ORLY) and maintained a price target of $1060.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:44 pm

ETN

Wells Fargo analyst Joseph O'Dea has maintained an Equal-Weight rating on Eaton Corp (NYSE:ETN) and increased the price target from $220 to $257.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:43 pm

AXP

MPC

TSM

On CNBC's 'Halftime Report Final Trades,' analysts shared their final trades, including U.S. 6 Month Treasury Bill, Taiwan Semiconductor (TSM), American Express (AXP), and Marathon Petroleum (MPC). TSM reported a revenue slump, while AXP and MPC received positive analyst ratings and price target adjustments from Goldman Sachs and Wells Fargo, respectively. TSM shares closed up 0.4%, AXP rose 1.3%, and MPC gained 2.3% in Monday's session.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 1:42 pm

ADM

F

GOOGL

HEI

LLY

TSLA

A new Solana-based meme coin has surged 2000% in less than a month. A US court approved a $2.7B settlement against Binance. Biden's approval rating drops amid inflation issues. Cathie Wood's Ark Invest shifts its crypto holdings. HEICO reports strong sales, and the Fear & Greed Index indicates 'Extreme Greed'. Tesla and Ford face potential impacts from EV tax credit changes. Google settles an antitrust case for $700M. Tesla shares rebound in premarket trading. Hyundai divests Russian facilities with a loss, and ADM acquires Revela Foods. Eli Lilly's shares may surge due to a new drug, according to Goldman Sachs.

Portfolio Pulse from Akanksha Bakshi

December 19, 2023 | 1:42 pm

EQNR

Equinor ASA (NYSE:EQNR) has signed a long-term gas sales agreement with Germany's SEFE worth EUR 50 billion, to supply 111 TWh of natural gas annually from 2024 to 2034, with an option to extend for another five years. Additionally, a non-binding LoI for SEFE to off-take low-carbon hydrogen from Equinor starting in 2029 was signed. Despite this, EQNR shares are trading lower by 1.04% in premarket.

Portfolio Pulse from Lekha Gupta

December 19, 2023 | 1:42 pm

IKT

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) issued a shareholder letter updating on its development programs. The company reported progress in its neurodegenerative and cancer therapeutics programs, with a 68% stock price increase since October. The 201 trial for risvodetinib in Parkinson's disease is enrolling patients, expecting results in H2 2024. The FDA granted Orphan Drug Designation for risvodetinib for Multiple System Atrophy. IkT-001Pro, a prodrug of imatinib, completed bioequivalence studies, and a pre-NDA meeting with the FDA is planned for early 2024. The company also developed a new tablet formulation for risvodetinib and is exploring non-oncology indications for IkT-001Pro.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:41 pm

DOV

Wells Fargo analyst Joseph O'Dea has maintained an Equal-Weight rating on Dover Corporation (NYSE:DOV) and increased the price target from $140 to $167.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:41 pm

FOXO

FOXO Technologies Inc. received a notice from NYSE Regulation for noncompliance with continued listing standards due to the late filing of its Form 10-Q. The company attributes the delay to recent restructuring and asserts its commitment to regaining compliance. The notice does not immediately affect the trading of FOXO's Class A common stock on the NYSE American.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:39 pm

CAAP

Corporación América Airports (CAAP) reported a 14.5% year-over-year increase in passenger traffic for November 2023, matching the traffic levels of November 2019. All countries where CAAP operates, except Brazil and Italy, have surpassed their November 2019 passenger traffic levels.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:35 pm

AYI

Wells Fargo analyst Joseph O'Dea has maintained an Overweight rating on Acuity Brands (NYSE:AYI) and increased the price target from $200 to $236.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:34 pm